Navigation Links
Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
Date:3/30/2009

d for re-election this year. The Company greatly appreciates Mr. Greene's and Ms. Graham's many years of dedicated service to build and grow the Company, both as directors and former leaders of Amylin.

Stockholders may review more detailed biographies of all Amylin's nominees in the Company's preliminary proxy statement filed today with the Securities and Exchange Commission.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information on Amylin Pharmaceuticals is available at www.amylin.com.

This press release contains forward-looking statements about Amylin that involve risks and uncertainties. The Company's actual results could differ materially from those discussed herein due to a number of risks and uncertainties, including risks and uncertainties that are described in the Company's recently filed annual report on Form 10-K. Amylin disclaims any obligation to update these forward-looking statements.

Additional Information and Where to Find It

This release may be deemed to be solicitation material in respect of the matters to be considered at the 2009 Annual Meeting of Stockholders. Amylin will be filing a proxy statement with the Securities and Exchange Commission ("SEC"). INVESTORS AND SECURITYHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Amylin Pharmaceuticals Comments on Shareholder 13-D Filing
2. Amylin Pharmaceuticals Reports 2008 Financial Results
3. Amylin Pharmaceuticals to Webcast Year-End Results
4. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
5. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
6. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
7. Lilly and Amylin Set Date and Time for Conference Call
8. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Amylin Pharmaceuticals Reports 2007 Financial Results
11. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... August 30, 2014 “In 2013, a vehicle ... Jones Firm says in a recently released article on ... was injured in an auto accident every 12 minutes, and ... they continue. “Based on the 2013 statistics, between now and ... collision.” , The threat of an auto accident is real ...
(Date:8/30/2014)... MA (PRWEB) August 30, 2014 Barton ... nurse practitioner locum tenens company , announces a ... September 1, 2014. Barton Associates is headquartered in Peabody, ... CT; Keene, NH; and Jupiter, FL. , ... to the increasing demand for healthcare providers. The United ...
(Date:8/30/2014)... 2014: The first multidisciplinary recommendations on the management ... (ACS) are published today in EP Europace ... by the European Heart Rhythm Association (EHRA), the ... Association of Percutaneous Cardiovascular Interventions (EAPCI), all of ... chairperson of the task force, said: "Sudden cardiac ...
(Date:8/30/2014)... Saturday 30 August 2014: The therapeutic benefit ... emphasised in the 2014 ESC/EACTS revascularisation guidelines presented ... Professor Stephan Windecker (Switzerland) of the European Society ... of the European Association for Cardio-Thoracic Surgery (EACTS). ... European Heart Journal (1), on the ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 AGH Healthy ... the Doctors in Delaware at Atlantic General ... free health-related services. In addition to no-cost blood pressure ... offers first aid care at local sports tournaments. ... other medical staff provide free disease management and falls ...
Breaking Medicine News(10 mins):Health News:Startling Washington Auto Accident Statistics Discussed In Recently Released Article By The Jones Firm 2Health News:Barton Associates Announces New Office Location in Austin, TX 2Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 2Health News:ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD 3Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3
... The pharmaceutical industry is a "market for lemons," a ... buyer about the product and can profit from selling products ... believe, according to an analysis that will be presented at ... "Sometimes drug companies hide or downplay information about serious side ...
... study shows the impact of alcohol intoxication on reasoning ... feel they have recovered enough to drive after drinking. ... president of research for Lifespan, is the first to ... rising and declining blood alcohol concentrations, at matched blood ...
... , TUESDAY, Aug. 17 (HealthDay News) -- Nearly 40 percent ... episodes of manic behavior, a new study suggests. Researchers ... that these patients have what,s called "subthreshold hypomania" -- meaning ... days, and is therefore below the threshold for bipolar disorder. ...
... Community Living Assistance Services and Supports (CLASS) Act a ... Care Act has the potential to transform long-term care ... insurance-based system, according to the latest issue of ... With funding from The SCAN Foundation , this ...
... for airway repair in the lung but that persist in ... poor prognosis in patients who develop cancer, even those with ... have found. These adult stem cells are found in ... areas, suggesting that these cells may mutate and become cancer ...
... an Aging America" will be the focus of the 24th ... Aging from 8 a.m. to 3:30 p.m. Wednesday, Sept. 8 ... The conference, sponsored by The University of Texas Health ... Aging, will include panel discussions, a keynote address by Robert ...
Cached Medicine News:Health News:Pharmaceuticals: A market for producing 'lemons' and serious harm 2Health News:Pharmaceuticals: A market for producing 'lemons' and serious harm 3Health News:Why drunk drivers may get behind the wheel 2Health News:Why drunk drivers may get behind the wheel 3Health News:Many Depressed People Have Mild, Brief Episodes of Mania 2Health News:CLASS Act analysis reveals America's long-term care future 2Health News:Lung stem cells vital to lung repair associated with poor cancer prognosis when found in tumor 2
(Date:8/29/2014)... Research and Markets has announced ... Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the aspects ... and business performance of domestic major enterprises, as well ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... The Professional Gold Package is ... laboratory. The package includes the ... automated system, starter package accessory ... adapter, specimen mounts 1/2" head, ...
... Semi-Automatic Tissue Sectioning System has maintained the ... system. Researchers from around the globe have ... their fresh and fresh fixed tissue sectioning ... With the Vibratome Automatic Tissue Sectioning Systems, ...
... Plus Sectioning System provides a versatile means ... plant tissues. The 1000 employs a ... freezing or embedding. The creation of ... of enzyme activities, and other deleterious effects ...
... with a square vice mounting device. ... for mounting specimens and placing in ... blocks are annodized black for easy ... They are shipped three to ...
Medicine Products: